BOK Financial Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11K Buy
+4
New +$2.24K ﹤0.01% 616
2025
Q1
– Sell
-2
Closed -$827 – 569
2024
Q4
$827 Buy
+2
New +$877 ﹤0.01% 526
2022
Q2
– Sell
-380
Closed -$208K – 407
2022
Q1
$208K Sell
380
-60
-14% -$31.6K 0.01% 295
2021
Q4
$290K Buy
440
+11
+3% +$6.91K 0.02% 231
2021
Q3
$267K Buy
429
+74
+21% +$49.7K 0.02% 209
2021
Q2
$224K Buy
+355
New +$196K 0.02% 209

Other funds holding IDXX

BOK Financial Private Wealth's IDXX Position: Q2 2026 in Review

BOK Financial Private Wealth opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 4 shares worth $2.11K. The stake represents ﹤0.01% of the portfolio and ranks #616 among its holdings. This is a return to the name: BOK Financial Private Wealth previously reported a position in IDXX as recently as Q4 2024.

BOK Financial Private Wealth first reported a position in IDXX in Q2 2021 and has held it in 6 quarters since. The position peaked at $290K in Q4 2021. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • BOK Financial Private Wealth held 4 shares of Idexx Laboratories worth $2.11K as of Q2 2026.
  • Idexx Laboratories was a new BOK Financial Private Wealth position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of BOK Financial Private Wealth's portfolio in Q2 2026, its #616 holding.
  • BOK Financial Private Wealth first reported a position in Idexx Laboratories in Q2 2021 and has held it in 6 quarters since.
  • BOK Financial Private Wealth's Idexx Laboratories position peaked at $290K in Q4 2021.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on BOK Financial Private Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.